VEGFA and type 2 diabetes mellitus: In humans, the release of pro-angiogenic vascular endothelial growth factor (VEGF) from PVAT of type 2 diabetics was significantly higher than that from PVAT of non-diabetic subjects or from subcutaneous adipose tissue of diabetics (Schlich et al., 2013).